Exemptia 40 mg/0.8 ml Injection
cold chainExemptia 40mg Injection contains the active ingredient Adalimumab. It is an antirheumatic agent that belongs to the class of medications called TNF (tumor necrosis factor) inhibitors. It is used alone or with other medications to relieve the symptoms of certain autoimmune disorders. It is used to treat rheumatoid arthritis (a condition in which the body attacks its joints, causing pain, swelling, and loss of function), polyarticular juvenile idiopathic arthritis (a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development).
₹25,000.00 Original price was: ₹25,000.00.₹12,000.00Current price is: ₹12,000.00.
5 in stock (can be backordered)
Add to wishlist Add to compareAsk about productDescription
About Exemptia 40 mg Injection:
Each pre-filled syringe Exemptia 40 mg Injection contains Adalimumab 40 mg, Succinic Acid NF, Sodium Chloride, L-Arginine Monohydrochloride , Sorbitol NF, Polysorbate 80 NF, Sodium Hydroxide NF and WFI q.s.
Use of Exemptia 40 mg Injection:
Exemptia 40 mg Injection is prescribed for the treatment of:
- Rheumatoid arthritis
- Juvenile Idiopathic Arthritis
- Psoriatic Arthritis
- Ulcerative colitis
- Ankylosing spondylitis
- Crohn’s disease
- Plaque Psoriasis
- Hidradenitis Suppurativa
Related products
-
+ wishlist+ compare
Istamet 50 mg/500 mg Tablet
₹171.00Original price was: ₹171.00.₹153.00Current price is: ₹153.00.Add to cart -
+ wishlist+ compare
Manforce 100 mg Tablet 4’s
₹255.00Original price was: ₹255.00.₹180.00Current price is: ₹180.00.Add to cart -
+ wishlist+ compare
Tobaresp Mistpules 5 x 5 ml
₹2,665.00Original price was: ₹2,665.00.₹2,000.00Current price is: ₹2,000.00.Add to cart -
+ wishlist+ compare
Abzorb Cream, 15 gm
₹99.00Original price was: ₹99.00.₹90.00Current price is: ₹90.00.Add to cart -
+ wishlist+ compare
Volini Pain Relief Gel, 50 gm
₹198.00Original price was: ₹198.00.₹180.00Current price is: ₹180.00.Add to cart
Reviews
There are no reviews yet.